TET2 and leukemia: Despite the epistatic relationship in the DNA methylation-hydroxymethylation pathway, DNMT3A and TET2 mutations are often concurrent in lymphoma and leukemia patients [97,98,99,100], suggesting that both enzymes sometimes work in parallel to produce a common result.